Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
Arthritis Research & Therapy|August 27, 2025
Association of exercise-induced pulmonary hypertension with nailfold capillary density in systemic sclerosis: a single-center retrospective observational studyKatsuhide Kusaka, Satoshi Kubo, Shingo Nakayamada, et al.
Bioorganic & Medicinal Chemistry|June 17, 2018
Optimization and in vivo evaluation of pyrazolopyridines as a potent and selective PI3Kδ inhibitorToshihiro Hamajima, Fumie Takahashi, Koji Kato, et al.
Arthritis and Rheumatism|December 8, 2011
The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cellsKeisuke Maeshima, Kunihiro Yamaoka, Satoshi Kubo, et al.
Journal of Neurology|January 27, 2018
Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patientsTomohisa Nezu, Takaya Kitano, Satoshi Kubo, et al.
Rheumatology (Oxford, England)|June 24, 2019
Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosisSatoshi Kubo, Shingo Nakayamada, Yusuke Miyazaki, et al.
RMD Open|June 13, 2024
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosusYurie Satoh-Kanda, Shingo Nakayamada, Satoshi Kubo, et al.
Clinical Immunology (Orlando, Fla.)|April 13, 2026
Short-chain fatty acid deficiency drives aberrant B cell differentiation in systemic lupus erythematosusRyuichiro Kanda, Satoshi Kubo, Kaoru Yamagata, et al.
Clinical Immunology (Orlando, Fla.)|December 22, 2018
Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosusMaiko Yoshikawa, Shingo Nakayamada, Satoshi Kubo, et al.
JMIR Mhealth and Uhealth|June 23, 2020
Health Observation App for COVID-19 Symptom Tracking Integrated With Personal Health Records: Proof of Concept and Practical Use StudyKeiichi Yamamoto, Tsubasa Takahashi, Miwa Urasaki, et al.
Rheumatology and Therapy|October 19, 2023
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST RegistrySatoshi Kubo, Yusuke Miyazaki, Yasuyuki Todoroki, et al.
Pageof 19